Pathophysiology of Huntington's Disease (HD). Peroxisome

Frontiers Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease

Mitochondria and Huntington's disease. Schematic diagram showing that

Huntington's disease: underlying molecular mechanisms and emerging concepts: Trends in Biochemical Sciences

Therapeutics for the treatment and management of Huntington's disease.

An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development

IJMS, Free Full-Text

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

Pathogenesis of Huntington's Disease: How to Fight Excitotoxicity and Transcriptional Dysregulation

Biomedicines, Free Full-Text

The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease

Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics: Trends in Molecular Medicine

Striatal infusion of cholesterol promotes dose‐dependent behavioral benefits and exerts disease‐modifying effects in Huntington's disease mice

Huntington's disease: from molecular pathogenesis to clinical treatment - ScienceDirect

Iron dysregulation in Huntington's disease - Muller - 2014 - Journal of Neurochemistry - Wiley Online Library

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis